Betnesol 0.5 mg

When prescribed for a suitable skin disorder, Betnesol may:

• Reduce severe skin inflammation

• Ease redness, itching and swelling

• Help control autoimmune blistering

• Reduce the formation of new inflammatory lesions

• Relieve discomfort caused by widespread inflammation

• Calm an excessive immune response

• Help protect skin from continuing inflammatory damage

Betnesol controls inflammation while treatment is active. It does not permanently cure an autoimmune skin disease, and symptoms can return if the underlying condition remains active.

Inflammatory skin conditions cause the immune system to release chemicals that produce redness, swelling, itching, warmth and tissue damage. In autoimmune skin disease, the immune system may mistakenly attack healthy skin.

Betamethasone enters cells and attaches to glucocorticoid receptors. This reduces the production and release of inflammatory chemicals, including prostaglandins, histamine and other immune signals.

As inflammation settles, redness, swelling, itching, blister formation and skin discomfort may improve. The same immune-suppressing effect can reduce the body’s ability to fight infection, which is why Betnesol requires medical supervision.

There is no single Betnesol dosage suitable for every condition. The dose depends on the diagnosed illness, its severity, the treatment response and how long corticosteroid therapy is required.

The official prescribing information provides the following adult dosage guidance:

• Short-term treatment: 2 mg to 3 mg daily for the first few days, followed by gradual reductions of 0.25 mg or 0.5 mg every two to five days according to the response.

• Rheumatoid arthritis: 0.5 mg to 2 mg daily, followed by the lowest dose that continues to control symptoms.

• Most other conditions: 1.5 mg to 5 mg daily for one to three weeks, followed by a gradual reduction to the minimum effective dose.

These are professional prescribing ranges and should not be used to select a dose without medical instructions. The daily amount may be divided, and the lowest dose that provides an acceptable result should be used.

Betnesol 0.5 mg tablets should be swallowed whole with water. The Indian GSK tablet should not be dissolved in water. Take each dose at the time stated on the prescription.

Do not stop Betnesol suddenly after prolonged treatment. The dose may need to be reduced in stages over several weeks or months so the adrenal glands can begin producing enough natural steroid hormone again.

If a dose is missed, take it when remembered unless the next dose is nearly due. Skip the missed dose when necessary and never take two doses together.

Common Side Effects: Possible effects include indigestion, nausea, increased appetite, difficulty sleeping, mood changes, irritability, fluid retention and increased blood sugar or blood pressure. Some people may also experience acne, easy bruising or slower wound healing. Tell the prescriber if these effects become troublesome or continue.

Serious Side Effects: Obtain medical help for signs of a severe infection, black or bloody stools, severe stomach pain, major mood or behaviour changes, suicidal thoughts, blurred vision, marked muscle weakness, unusual swelling, breathing difficulty or a serious allergic reaction. Long-term treatment can increase the risk of osteoporosis, glaucoma, cataracts, diabetes, adrenal suppression and Cushing-like changes. Stopping treatment too quickly can cause severe weakness, low blood pressure and acute adrenal insufficiency.

Betnesol should not be used without medical approval by:

• People allergic to betamethasone

• People with untreated systemic infections

• People receiving live-virus vaccines

• People with active tuberculosis

• People with uncontrolled diabetes

• People with severe hypertension

• People with glaucoma

• People with osteoporosis

• People with active peptic ulcers

• People with severe psychiatric disorders

• Pregnant or breastfeeding women

• Children without specialist supervision

Some of these conditions do not always prevent treatment, but they require an individual assessment and closer medical monitoring.

Tell the doctor or pharmacist about all medicines, supplements and vaccines being used.

Important interactions include:

• Live vaccines

• Aspirin and other NSAIDs

• Warfarin and other anticoagulants

• Insulin and diabetes medicines

• Diuretics

• Digoxin

• Rifampicin

• Phenytoin or carbamazepine

• Ritonavir or cobicistat

• Itraconazole

NSAIDs can increase the risk of stomach ulceration or bleeding when combined with an oral corticosteroid. Some medicines can lower betamethasone levels, while ritonavir, cobicistat and itraconazole may increase steroid exposure and side effects.

Do not receive a live vaccine or begin another prescription treatment without informing the healthcare professional managing Betnesol therapy.

Important Skin Infection Warning - Betnesol can suppress inflammation so effectively that redness, pain and fever caused by an infection become less noticeable. The infection may continue to spread even when the skin appears temporarily calmer. Seek medical advice if the affected skin becomes warmer, more painful, swollen, produces pus, develops rapidly spreading redness or is accompanied by fever. Antibacterial, antifungal or antiviral treatment may be required.

• Store Betnesol below 30°C.

• Protect the tablets from direct light.

• Keep them in their original aluminium strip.

• Protect them from heat and moisture.

• Keep them away from children and pets.

• Do not use damaged or discoloured tablets.

• Do not use the medicine after its expiry date.

• Follow any additional instructions printed on the pack.